13F Data
13F filer · CIK 1389933

DAFNA Capital Management LLC

LOS ANGELES, CA · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$524.4M
+$84.8M vs prior
Positions
88
New / sold out
17 / 12
Added / reduced
17 / 26
Turnover
15.8%
buys $76.1M · sells $114.7M
Top-10 weight
56.2%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewASCENDIS PHARMA A/S+48,469–+$12.9M
AddedDENALI THERAPEUTICS INC+420,514+132.0%+$10.8M
AddedNEKTAR THERAPEUTICS+153,202+92.7%+$10.7M
AddedINSULET CORP+51,000+469.2%+$7.8M
AddedEDGEWISE THERAPEUTICS INC+114,583+102.1%+$4.7M
NewKYMERA THERAPEUTICS INC+27,000–+$3.1M
NewADLAI NORTYE LTD+239,553–+$2.8M
AddedSYNDAX PHARMACEUTICALS INC+117,900+54.2%+$2.6M
NewNERVGEN PHARMA CORP+1,050,000–+$2.2M
AddedORTHOPEDIATRICS CORP+93,471+97.7%+$1.8M
24 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outDAY ONE BIOPHARMACEUTICALS I-978,463-100.0%$-21.0M
ReducedSPDR S&P BIOTECH ETF-122,000-38.3%$-19.3M
ReducedBIOHAVEN LTD-708,142-83.7%$-10.5M
ReducedMBX BIOSCIENCES INC-163,656-93.3%$-9.0M
Sold outASCENDIS PHARMA A/S-4,000,000-100.0%$-5.9M
ReducedCOMPASS PATHWAYS PLC-406,930-16.8%$-5.8M
Sold outKALVISTA PHARMACEUTICALS INC-267,402-100.0%$-5.4M
Sold outASCENDIS PHARMA A/S-23,177-100.0%$-5.3M
ReducedBICARA THERAPEUTICS INC-136,778-32.4%$-4.1M
ReducedCYTOKINETICS INC-45,499-20.9%$-3.9M
28 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $68.3MQ3 2013: $91.5MQ4 2013: $97.2MQ1 2014: $116.3MQ2 2014: $105.5MQ3 2014: $99.1MQ4 2014: $126.4MQ1 2015: $130.2MQ2 2015: $118.2MQ3 2015: $100.8MQ4 2015: $112.2MQ1 2016: $115.9MQ2 2016: $126.2MQ3 2016: $143.6MQ4 2016: $113.8MQ1 2017: $118.2MQ2 2017: $140.1MQ3 2017: $161.1MQ4 2017: $185.7MQ1 2018: $205.6MQ2 2018: $213.6MQ3 2018: $243.5MQ4 2018: $201.1MQ1 2019: $231.8MQ2 2019: $266.0MQ3 2019: $265.9MQ4 2019: $291.3MQ1 2020: $239.6MQ2 2020: $346.5MQ3 2020: $307.6MQ4 2020: $336.1MQ1 2021: $421.5MQ2 2021: $478.2MQ3 2021: $376.9MQ4 2021: $397.7MQ1 2022: $383.8MQ2 2022: $366.9MQ3 2022: $371.8MQ4 2022: $355.1MQ1 2023: $333.5MQ2 2023: $365.7MQ3 2023: $321.5MQ4 2023: $417.3MQ1 2024: $439.3MQ2 2024: $418.6MQ3 2024: $423.3MQ4 2024: $393.4MQ1 2025: $352.7MQ2 2025: $362.3MQ3 2025: $404.8MQ4 2025: $430.5MQ1 2026: $439.6MQ2 2026: $524.4M
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1REVOLUTION MEDICINES INCCOM562,630$105.4M20.09%
2SPDR S&P BIOTECH ETFETF196,505$31.1M5.93%
3COMPASS PATHWAYS PLCSPONSORED ADS2,011,952$28.5M5.43%
4STEREOTAXIS INCCOM NEW13,680,554$23.5M4.49%
5NEKTAR THERAPEUTICSCOM NEW318,380$22.2M4.24%
6DENALI THERAPEUTICS INCCOM739,014$19.0M3.62%
7IDEAYA BIOSCIENCES INCCOM497,240$18.5M3.53%
8ATRICURE INCCOM597,431$16.7M3.19%
9XENON PHARMACEUTICALS INCCOM250,772$15.1M2.89%
10CYTOKINETICS INCCOM NEW171,998$14.7M2.79%
78 more rows. Subscribe for $29/month to see every row, download the data and use the API.